You are here

Characteristics of Chemotherapy-Induced Neuropathy

Workflow State: 
Approved
Type of proposal: 
Participant recruitment (what is this?)
Does this project have funding?: 
Yes

Researcher Information

First name: 
Christine
Last name: 
Miaskowski
Degree: 
PhD
Work phone number: 
(415) 476-5131

Institution Information

University of California, San Francisco
2 Koret Way, N631
94143 San Francisco , CA
United States

Project Information

List of Collaborators: 
Bradley Aouizerat, PhD Lee-May Chen, MD Michelle Melisko, MD Gary Abrams, MD Kimberly Topp, PhD, PT
Number of Participants Needed: 
600
Inclusion and Exclusion Criteria: 
Descriptive Study: Part 1 Inclusion Criteria : People 18 years of age or older Read and understand English Received a taxane or platinum based chemotherapy Have completed chemotherapy for at least 3 months Either NEVER experienced neuropathy OR continue to have symptoms of neuropathy Exclusion Criteria: History of peripheral vascular disease, vitamin B12 deficiency, untreated thyroid dysfunction, HIV neuropathy,or any painful condition that is difficult to distinguish from chemotherapy-induced neuropathy. Intervention Study: Part 2 Inclusion: Participated in Part 1 Have neuropathy in feet Able to attend 8 visits over the course of 2 weeks in San Francisco Exclusion Criteria: Diabetes

Project Details

Primary Area of Study: 
Secondary Area of Study: 
IRB Approval: 
Yes
Legacy Date Received: 
2015-01-09 12:27:43